Effectiveness and safety in Crohn's disease patients who were treated with CT-P13

被引：0
|
作者：
Choe, Y. H. [1 ]
Lee, S. -H. [2 ]
Park, D. I. [3 ]
Lee, J. H. [4 ]
Kim, H. J. [5 ]
Kim, Y. -H. [6 ]
Choi, C. H. [7 ]
Eun, C. S. [8 ]
Lee, S. J. [9 ]
Lee, S. [9 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Pediat, Samsung Med Ctr, Seoul, South Korea
[2] Esoo Hosp, Digest Endoscop Ctr, Cheonan Si, South Korea
[3] Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea
[4] Seoul Song Do Colorectal Hosp, Dept Internal Med, Seoul, South Korea
[5] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Samsung Med Ctr, Seoul, South Korea
[7] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[8] Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, South Korea
[9] CELLTRION Inc, Incheon, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
INFLIXIMAB;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P500
引用
收藏
页码：S333 / S333
页数：1
相关论文
共 50 条
  • [21] SWITCHING FROM INFLIXIMAB ORIGINATOR TO THE BIOSIMILAR (CT-P13) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE STUDY ABOUT EFFECTIVENESS AND SAFETY
    Annulli, G.
    Quatraccioni, C.
    Daretti, L. M.
    Antuono, S.
    Guardati, P.
    Calzolari, M.
    Benedetti, A.
    Di Sario, A.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S134 - S135
  • [22] Editorial: subcutaneous CT-P13 in Crohn's disease and ulcerative colitis-small change, big consequences
    Carbonnel, Franck
    Meyer, Antoine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (02) : 251 - 252
  • [23] Effectiveness and safety of switching patients with inflammatory bowel disease from originator infliximab to CT-P13: systematic review and meta-analysis
    Hanzel, J.
    Strik, A.
    Gecse, K.
    D'Haens, G.
    Dreesen, E.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S367 - S368
  • [24] SAFETY AND EFFECTIVENESS OF CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM 24 MONTHS NATIONWIDE REGISTRY IN KOREA
    Park, S. H.
    Nah, S. S.
    Chang, S. H.
    Kim, K. J.
    Park, K. S.
    Lee, S. S.
    Kwon, S. R.
    Lee, S. I.
    Suh, C. H.
    Kim, S. H.
    Son, C. N.
    Min, J. K.
    Kim, H. R.
    Beak, H. J.
    Kim, H. S.
    Choe, J. Y.
    Yang, H. I.
    Lim, M. K.
    Hong, S. J.
    Kim, Y. S.
    Lee, J. H.
    Suh, J.
    Lee, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1185 - 1186
  • [25] Subcutaneous CT-P13 for inflammatory bowel disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (05): : 347 - 347
  • [26] Efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
    Jung, Yoon Suk
    Park, Dong Il
    Kim, Young Ho
    Lee, Ji Hyun
    Seo, Pyoung Ju
    Cheon, Jae Hee
    Kang, Hyoun Woo
    Kim, Ji Won
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1705 - 1712
  • [27] Efficacy and Safety of CT-P13 (Infliximab Biosimilar) Over Two Years in Patients with Rheumatoid Arthritis: Comparison Between Continued CT-P13 and Switching from Infliximab to CT-P13.
    不详
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3319 - 3319
  • [28] CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel disease
    Schulze, Kornelius
    Koppka, Nadine
    Lutter, Frederik
    Brandhorst, Gunnar
    Schreiber, Stefan
    Helwig, Ulf
    BIOLOGICALS, 2016, 44 (05) : 463 - 466
  • [29] Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease
    Fiorino, G.
    Ruiz-Aguello, M. B.
    Maguregui, A.
    Nagore, D.
    Radice, S.
    Gilardi, D.
    Correale, C.
    Allocca, M.
    Furfaro, F.
    Alfieri, M.
    Martinez, A.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S403 - S404
  • [30] ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE
    Fiorino, Gionata
    Ruiz-Arguello, Begona
    Maguregui, Ainara
    Nagore, Daniel
    Radice, Simona
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Furfaro, Federica
    Alfieri, Marina F.
    Maritnez, Antonio
    Danese, Silvio
    GASTROENTEROLOGY, 2017, 152 (05) : S386 - S386
12345